The effect of bebtelovimab on clinical outcomes in patients with COVID-19: A meta-analysis

被引：4
|
作者：
Luo, Jie [1 ]
Li, Toni [2 ]
Liu, Changying [3 ]
Wang, Yushu [4 ]
Tran, Carolyn [5 ]
Ao, Guangyu [1 ,6 ]
机构：
[1] Chengdu First Peoples Hosp, Dept Nephrol, Chengdu, Sichuan, Peoples R China
[2] Queens Univ, Sch Med, Kingston, ON, Canada
[3] Gen Hosp Western Theater Command, Dept Geriatr, Peoples Liberat Army, Chengdu, Peoples R China
[4] Chengdu West China Clin Res Ctr, Chengdu, Sichuan, Peoples R China
[5] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[6] 18 Wanxiang North Rd, Chengdu 610095, Sichuan, Peoples R China
来源：
JOURNAL OF INFECTION | 2023年 / 87卷 / 01期
关键词：
D O I：
10.1016/j.jinf.2023.04.010
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：68 / 71
页数：4
相关论文
共 50 条
  • [21] Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials
    Ghaempanah, Faezeh
    Nikouei, Maziar
    Cheraghi, Mojtaba
    Jahangiri, Arman
    Moradi, Yousef
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [22] The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Mohamed Abuelazm
    Ahmed Ghanem
    Ahmed K. Awad
    Ramadan Abdelmoez Farahat
    Fatma Labieb
    Basant E. Katamesh
    Basel Abdelazeem
    Clinical Drug Investigation, 2022, 42 : 1031 - 1047
  • [23] The effect of influenza vaccine in reducing the severity of clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
    Hossam Waleed Almadhoon
    Aboalmagd Hamdallah
    Sarah Makram Elsayed
    Abdulrahman Ibrahim Hagrass
    Mohammed Tarek Hasan
    Aya Mamdouh Fayoud
    Mohammed Al-kafarna
    Mohammad Elbahnasawy
    Fadel Alqatati
    Khaled Mohamed Ragab
    Mohamed Sayed Zaazouee
    Elfatih A. Hasabo
    Scientific Reports, 12
  • [24] Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials
    Faezeh Ghaempanah
    Maziar Nikouei
    Mojtaba Cheraghi
    Arman Jahangiri
    Yousef Moradi
    Journal of Pharmaceutical Policy and Practice, 16
  • [25] The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Abuelazm, Mohamed
    Ghanem, Ahmed
    Awad, Ahmed K.
    Farahat, Ramadan Abdelmoez
    Labieb, Fatma
    Katamesh, Basant E.
    Abdelazeem, Basel
    CLINICAL DRUG INVESTIGATION, 2022, 42 (12) : 1031 - 1047
  • [26] Efficacy and safety outcomes with remdesivir in COVID-19 patients: A meta-analysis
    Tejas Kamleshbhai Patel
    Parvati B Patel
    Manish Barvaliya
    Vijayalaxmi
    Hira Lal Bhalla
    World Journal of Meta-Analysis, 2021, 9 (01) : 74 - 87
  • [27] Is Rituximab Associated with Worse Outcomes in COVID-19 Patients? A Meta-analysis
    Gerais, Yasmin
    Sun, Chenyu
    King, Bethany
    Lowe, Scott
    Mohammed, Biniyam
    Bentley, Rachel
    Li, Yaru
    Wei, Binyu
    Xu, Chuanhui
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 263 - 265
  • [28] Early intubation and clinical outcomes in patients with severe COVID-19: a systematic review and meta-analysis
    Hyeon-Jeong Lee
    Joohae Kim
    Miyoung Choi
    Won-Il Choi
    Joonsung Joh
    Jungeun Park
    Junghyun Kim
    European Journal of Medical Research, 27
  • [29] Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis
    Kunutsor, Setor K.
    Laukkanen, Jari A.
    JOURNAL OF INFECTION, 2021, 82 (01) : 186 - 190
  • [30] Tracheostomy timing and clinical outcomes in ventilated COVID-19 patients: a systematic review and meta-analysis
    Ji, Yun
    Fang, Yumin
    Cheng, Baoli
    Li, Libin
    Fang, Xiangming
    CRITICAL CARE, 2022, 26 (01)
12345